BioSpace News Archive

The official joint replacement products of the PGA TOUR®, Stryker, makes its first appearance at the Sioux Falls tournament

Novo Nordisk Canada Inc. announces that Ontario will now reimburse TRESIBA® (insulin degludec injection) FlexTouch® prefilled pen in both 100 units/mL and 200 units/mL doses, as a general benefit for people living with Type 2 and Type 1 diabetes.

This gift, the largest contribution ever received by Family Reach, will provide critical financial services, support programs and educational resources to families across the United States struggling with the financial burden of a child’s cancer diagnosis

b-ONE Ortho Corp. today announced it has received 510(k) clearance for its first device, the b-ONETM Total Hip System, from the U.S. Food and Drug Administration (FDA).

JOOL Health today announced a new partnership to bring JOOL’s groundbreaking solution to the faculty and staff of the University of Delaware. JOOL is a digital personal life coach that improves overall employee well-being and organizational performance, by combining the science of purpose with advanced data analytics.

Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Fulphila®, a biosimilar to Amgen’s Neulasta® (pegfilgrastim).

Hands-on laboratory moves science-based teaching and learning into the future

Colgate-Palmolive has been named to the Dow Jones Sustainability Indices (DJSI) for the second consecutive year in recognition of the company’s demonstrated commitment to sustainability goals and ethical behavior, as well as the value it has generated for shareholders.

Bill and Giuliana Rancic to Lend Expertise, Passion and Personal Cancer Experience to Inspire Fellow Entrepreneurs

The NCCN 13th Annual Congress: Hematologic Malignancies™ examines novel treatments, major milestones, and challenging case studies for hematologic oncology. Join the conversation online with the hashtag #NCCNhem18.